
Clinical Infectious Diseases (CID) is a leading peer-reviewed medical journal that serves as a critical resource for clinicians, researchers, and healthcare professionals specializing in infectious diseases. Published by the Infectious Diseases Society of America (IDSA), CID is renowned for its rigorous research articles, clinical guidelines, and expert opinions that shape the global understanding of infectious diseases and influence clinical practice.
CID focuses on the diagnosis, prevention, and treatment of infectious diseases in both adult and pediatric populations. It publishes a wide range of content, including:
Original research articles
Clinical guidelines and practice recommendations
Case studies and clinical commentaries
Systematic reviews and meta-analyses
With a strong emphasis on evidence-based medicine, the journal plays a pivotal role in shaping infectious disease policy and practice worldwide.
Clinical Infectious Diseases addresses a broad spectrum of topics, including but not limited to:
Emerging and re-emerging infections (e.g., COVID-19, monkeypox)
Antimicrobial resistance and stewardship
HIV/AIDS and other viral infections
Vaccine development and immunization practices
Fungal, bacterial, parasitic, and zoonotic infections
Global health and epidemiology
The journal is particularly influential in addressing timely public health concerns, providing authoritative guidance during outbreaks and pandemics.
With a high impact factor, CID is one of the most cited journals in the field of infectious diseases. It caters to a diverse audience, including:
Infectious disease physicians
Epidemiologists
Public health officials
Clinical microbiologists
Medical researchers
Pharmacists and infection control specialists
Its wide readership and strong citation metrics underscore its importance as a primary source of information for professionals making evidence-based decisions in clinical and public health settings.
As global health threats continue to evolve, the need for trusted, peer-reviewed sources is more important than ever. CID serves as a cornerstone for up-to-date clinical insights, helping practitioners stay ahead of rapidly changing disease patterns, new treatment protocols, and preventive strategies.
CID’s commitment to quality and relevance makes it an indispensable tool for advancing patient care, informing policy, and driving innovation in infectious disease research.
In the constantly evolving field of healthcare, infectious diseases remain a critical area of study and clinical practice. As global health challenges like COVID-19, antimicrobial resistance, and emerging zoonotic infections continue to escalate, the need for reliable, up-to-date medical information has never been greater. This is where Clinical Infectious Diseases (CID) — a premier peer-reviewed medical journal — plays an essential role.
Published by the Infectious Diseases Society of America (IDSA), Clinical Infectious Diseases is an authoritative source for research, guidelines, and clinical updates related to infectious diseases. With a strong impact factor and global readership, CID provides evidence-based insights to clinicians, researchers, and public health professionals worldwide.
Clinical Infectious Diseases is a leading scientific journal dedicated to the field of infectious diseases. It publishes high-quality content, including:
Original clinical research studies
Review articles and meta-analyses
Case reports and expert commentaries
Clinical practice guidelines
CID focuses on improving the diagnosis, treatment, prevention, and management of infectious diseases in both adult and pediatric populations. Its articles are rigorously peer-reviewed, ensuring that the information is accurate, timely, and clinically relevant.
CID covers a broad range of infectious disease topics, making it a comprehensive resource for medical professionals. Common subjects include:
Viral infections such as influenza, HIV/AIDS, hepatitis, and COVID-19
Antimicrobial resistance and antibiotic stewardship
Bacterial and fungal infections
Vaccines and immunization strategies
Healthcare-associated infections and infection control
Travel and tropical medicine
The journal also frequently addresses pressing public health concerns, offering expert insights and timely recommendations during outbreaks and pandemics.
CID is widely read by:
Infectious disease physicians
Epidemiologists and microbiologists
Pharmacists and infection prevention specialists
Medical researchers and students
Global health experts and policymakers
The journal’s diverse readership reflects its influence in both academic and clinical settings. Its articles often serve as the foundation for national and international infectious disease guidelines and protocols.
In a world facing frequent infectious disease threats, having access to trustworthy, peer-reviewed information is crucial. Clinical Infectious Diseases stands out as a beacon of scientific integrity, helping healthcare professionals make informed decisions based on the latest evidence.
Its commitment to advancing medical knowledge and promoting effective disease prevention and treatment strategies makes it a vital resource in the fight against global infectious diseases.
Clinical Infectious Diseases (CID) is a highly respected, peer-reviewed medical journal that serves as a premier resource for the latest developments in the prevention, diagnosis, and treatment of infectious diseases. Published by the Infectious Diseases Society of America (IDSA), CID plays a vital role in bridging the gap between research and clinical practice, offering valuable insights for healthcare professionals, researchers, and policymakers around the globe.
The scope of Clinical Infectious Diseases spans a wide array of infectious disease topics, ensuring that it remains relevant to a broad audience within the medical and scientific communities. The journal publishes original research articles, systematic reviews, clinical guidelines, case reports, and expert commentaries.
Key areas of focus include:
Emerging and re-emerging infections such as COVID-19, mpox (monkeypox), Ebola, and other novel pathogens
Antimicrobial resistance (AMR) and strategies for antibiotic stewardship
HIV/AIDS and sexually transmitted infections (STIs)
Fungal, bacterial, and parasitic infections
Vaccine development, immunization programs, and vaccine hesitancy
Healthcare-associated infections and infection control
Global health and travel medicine
Public health policy, epidemiology, and outbreak response
The journal’s broad scope ensures that it remains at the forefront of major health issues affecting both developed and developing nations.
CID is tailored for an interdisciplinary audience, including:
Infectious disease specialists
Epidemiologists and microbiologists
Hospitalists and general practitioners
Public health officials
Clinical pharmacologists and pharmacists
Biomedical researchers
Medical educators and students
The journal’s content is widely cited and trusted by medical professionals, academic institutions, and health organizations, making it one of the most influential publications in the field.
As the world continues to face unpredictable outbreaks and rising antimicrobial resistance, the importance of a trusted, evidence-based resource like Clinical Infectious Diseases cannot be overstated. The journal delivers clinically applicable research and timely guidance to support optimal patient care and health outcomes.
CID also plays a central role in setting the standards for infectious disease management by publishing consensus guidelines developed by IDSA and other leading health bodies. These guidelines are widely adopted by hospitals, clinics, and public health organizations worldwide.
Clinical Infectious Diseases maintains a strong commitment to scientific rigor, peer review, and clinical relevance. Each article undergoes a thorough review process to ensure the highest quality of evidence and clarity. The journal continuously adapts its content to reflect the latest scientific advancements, public health trends, and clinical challenges.